is preparing...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$0.17 would sure be nice.
But when they set price targets like that, don't they usually imply 6 to 12 months? If the CC deal goes well, I can surely see $0.17 in that general timeframe.
Gap up, and now begins the profit-taking.
I'll bet! I'll take some 5-cent action, please!
0.052 was one of the fat finger trades, I think.
My streamer shows a 600K share trade went through at 4:38PM at 0.0052. So I'm not sure what that's all about....tape painting?
Bid and Ask still show the correct EOD numbers: 0.0116 x 0.0117
Indeed. Congratulations ladies and gents. Today was good...now we move onward and upward!
Welcome to the .007's, fellas. Keep on movin'!
Haha. I'm considering it!
FYI - Current HOD (without fat fingers) is .0068. Strong buying, so we may see .007's soon.
Highest I saw was .0055.
Wow. Fat finger at .042 made my portfolio look NICE!
Pausing in the low .004's. Hope to continue upward.
Wow. What's happening? No news (yet) to support this plummet? :|
That's EXACTLY what I was thinking! Trip to the UK.
C'mon. Let's go FCCN! Up 18%, currently.
The question is: will the news be good or bad?
We were up in the morning, and now we're suddenly down 22%.
Here's hoping for the best!
We've been in a bit of a lull lately. We might be heading back upward.
Is there any news on the horizon? Any deals, financing, or additional franchises completing soon?
Indeed. It's a moderate drop, but the volume is still very weak!
Prep for another run? Not sure.
I'm ready for good ol' "PR Pop" here, too!
PHOX prepping to run?
Up 35% so far.
EDIT: From Dow Jones (in my streamer) RMBS up 17% on takeover speculation...
Now, "Analysts dismiss rumor as unsubstantiated"
That's all I got.
I hope you've been watching lately. We've moved up considerably in the last 3 days. Let's hope that this time it sticks!
As far as I understand things, yes we should see a huge short covering (if Frank's shares were in Street Name). And correct....they have no other choice but to cover.
If his stock was held in Street Name, then shorters could short/borrow his stock. By converting them to preferred stock, they are no longer tradeable like that. Shorty has to cover what they've borrowed out of his 53%.
Of course, if all of his stock was already in Certificate form before the conversion, then this will do nothing for us.
As far as the Dateline program goes, it was horrible. The stock segment was on first and was only about 15 minutes long. It was basically the story of EagleTech. How it was started, how the stock price shot up and then 'inexplicably' began its decline.
They did mention the term Naked Short Selling as a possibility and named Salomon Smith Barney as the possible source of the counterfeiting. When describing naked short selling they said "this term is too complicated to explain on this program." And of course, the SEC refused to comment as well. All in all, with all of the hype that I've seen about it on the boards, it was very lame.
GO FCCN....eom
Interesting. New ownership and a new company direction. Dr. Albert A. Gomez has purchased and become CEO and President of Cybertel. It appears we're now working on developing Strategic Healthcare Systems, Inc.
"Dr. Gomez founded Strategic Healthcare Systems, Inc. in 1996 to improve access to affordable quality healthcare for all Americans and immigrants."
I wonder what "improve access" means...and what all it entails?
I say this is good because the company has a new owner and a new direction...all of this happened pretty quickly, considering the scary language Cybertel used in explaining that we were going nowhere fast. This is also bad and ugly because we're likely starting at "square one" once again, so it may be some time before we find out if we'll be profitable or successful with this endeavor.
I guess this means no more oil, and no more CPhones.
Keeping the fingers crossed.
I certainly HOPE they start mentioning the sponsor. Since people can subscribe to these podcasts (similar to RSS feeds for blogs, etc.), I'm under the impression that they can be downloaded without even going to the site. So very FEW people would see the banner.
Interesting...
Sure enough, scroll to the bottom of http://www.dvdweeklypodcast.com/ to see our link.
As far as more exposure goes...it's a start.
----------------------------------
GameZnFlix Becomes Sponsor of DVD Weekly Podcast
Tuesday June 21, 10:21 am ET
FRANKLIN, Ky., June 21 /PRNewswire-FirstCall/ -- GameZnFlix, Inc. (OTC Bulletin Board: GZFX - News), an online provider of DVDs and video games for rent or purchase, today announced that it has become the exclusive sponsor of "DVD Weekly" -- a weekly podcast program covering hot DVD releases and news.
ADVERTISEMENT
"DVD Weekly's popularity is surging -- the show is fantastic and they provide excellent content and commentary about DVDs," said Chip Gallent, President of GameZnFlix, Inc. "DVD Weekly has produced less than a dozen shows and is already topping over 1,000 downloads per show."
Podcasting enables independent producers to create self-published, syndicated "radio" shows in a way that users can subscribe to audio feeds and receive new audio files automatically to their computer or portable audio player. Users can also directly download and listen to these shows from their websites. DVD Weekly is available at http://www.dvdweeklypodcast.com.
"We're growing fast and GameZnFlix is a great partner for our show because they offer to our listeners what we're talking about -- great DVDs and the news surrounding the best releases," says Don Schockow, co-host of DVD Weekly. "We are so excited to have them on board and look forward to the synergies we can offer one-another."
GameZnFlix is a company that offers video games/DVD movies for rental or purchase on the Internet with access to over about 30,000 games and movie titles. With six different membership levels beginning at $17.25 a month to annual membership with an average price of $15.85 per month subscribers can rent a combination of both video games and/or DVD movies with no late fees or due dates or members can purchase video games and/or DVD movie titles at a membership discount.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward looking statements are further qualified by other factors including, but not limited to those set forth in the company's Form 10-KSB filing and other filings with the United States Securities and Exchange Commission (available at http://www.sec.gov/). The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
For further information, please contact GameZnFlix, Inc. corporate offices at 1 (888) 542-6817. Source Website: www.gameznflix.com.
I'll be at Gay Pride Chicago, so I can keep my eyes peeled for them.
I'm sure there are plenty of investors that would. Synthetic diamonds, while now possible, don't have the means for true mass production yet. And until consumers actually get comfortable with the quality of synthetic diamonds, they'll prefer the real thing. There's just a big appeal for something that nature took millions of years to create....and you're wearing that "thing" on your finger, neck, etc. Amazing!
Meanwhile, there's a big push for "conflict-free" diamonds. With South American and South African diamonds directly fueling terrorism and other separatist regimes, people are looking to buy from peaceful areas (like Canada) that won't aid in these regimes' causes.
Sorry if this sounded like some political action statement. It wasn't meant to be that way. I just think the newbie or average investor doesn't realize the whole diamond story.
OT: Ah, yes. Good ol' xxdiamdonchildxx. I hope that your opinions are correct. GO CMKX.
Don't worry, you two aren't alone. ;)
Good news...and we're UP, for once!
===================================
U.S. Navy Seeks FDA Okay to Start Trauma Trial of Hemopure(R)
Monday June 13, 6:55 am ET
Naval Medical Research Center Submits IND Application for Proposed "RESUS" Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
CAMBRIDGE, Mass., June 13 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPURD; BPUR) announced today that the U.S. Naval Medical Research Center (NMRC) has submitted to the Food and Drug Administration (FDA) an investigational new drug (IND) application to conduct a two-stage clinical trial of the company's oxygen therapeutic Hemopure® [hemoglobin glutamer - 250 (bovine)] for the out-of-hospital treatment of trauma patients. Under a research agreement with Biopure, the NMRC has primary responsibility for designing, seeking FDA acceptance of and directing the trial, entitled "Restore Effective Survival in Shock (RESUS)".
RESUS is designed as a single-blinded, multicenter, randomized, controlled, Phase IIb/III study. The objective is to assess the safety and efficacy of Hemopure, as compared to standard treatment, in reducing morbidity and mortality in severely injured patients experiencing hemorrhagic shock (acute blood loss) in the out-of-hospital setting, where blood is not available for transfusion. Patients would be randomized to receive either Hemopure or standard therapy at the scene of the injury and during transport to the hospital. The trial would require an exception from informed consent and would include a community consultation and disclosure program, as defined in federal regulations 21 CFR 50.24-25. Before the trial can proceed, the FDA and the participating hospitals' internal review boards must review and accept the study protocol.
RESUS represents a unique collaboration between scientists and clinicians from the military, academic hospitals, a nonprofit organization and Biopure under the direction and main funding of the NMRC. To date, Congress has appropriated a total of $18.5 million to the Navy and Army* for the development of Hemopure for potential use in military and civilian trauma indications and to cover military administrative costs. This funding is being used for RESUS and for preclinical studies of Hemopure in animal models of hemorrhagic shock, including those that mimic military trauma scenarios.
Out-of-Hospital Trauma
Traumatic injuries may cause massive bleeding resulting in rapid loss of oxygen-carrying capacity. Due to logistical issues, red blood cells are not typically administered in emergency situations outside of the hospital; emergency caregivers administer intravenous fluids (Ringer's lactate, saline) that restore blood volume but do not carry oxygen. If safety and effectiveness can be demonstrated and regulatory approval obtained, the company believes that the room- and elevated-temperature stability (3 years at 2 to 30 degrees Celsius, 18 months at 40 C), universal compatibility and other properties of Hemopure could allow it to be stockpiled, positioned abroad, and carried or stored in remote locations. These attributes may make it well suited for use on the battlefield, in ambulances, and in the Strategic National Stockpile.
Biopure Corporation
Biopure Corporation develops and manufactures intravenously administered pharmaceuticals, called oxygen therapeutics, that deliver oxygen to the body's tissues. The company is developing Hemopure® [hemoglobin glutamer - 250 (bovine)], or HBOC-201, for a potential indication in cardiovascular ischemia and, in collaboration with the U.S. Naval Medical Research Center, for an out- of-hospital trauma indication. The product is approved in South Africa for treating surgery patients who are acutely anemic and for eliminating, delaying or reducing allogeneic red blood cell transfusions in these patients. Hemopure has not been approved for sale in any other jurisdictions, including the United States or the European Union. Biopure's veterinary product Oxyglobin® [hemoglobin glutamer - 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs.
Statements in this press release that are not strictly historical, including those about the FDA and the hospital internal review boards allowing the RESUS trial to proceed, are forward-looking statements. Actual results may differ materially from those projected in these forward-looking statements due to risks and uncertainties regarding the company's operations and business environment. These risks include, without limitation, uncertainties regarding the company's ability to generate revenues, cash requirements, unexpected costs and expenses, insurance coverage, and possible delays and unforeseen costs related to clinical trials, regulatory approvals and marketing and distribution of the company's products. The company undertakes no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof. A full discussion of the company's operations and financial condition, and specific factors that could cause the company's actual performance to differ from current expectations, can be found in the company's filings with the U.S. Securities and Exchange Commission, including the Form 10-Q filed on June 9, 2005, which can be accessed in the EDGAR database at the SEC Web site, http://www.sec.gov, or through the Investor Relations section of Biopure's website, http://www.biopure.com.
The content of this press release does not necessarily reflect the position or the policy of the U.S. Government or the Department of Defense, and no official endorsement should be inferred. Completion of the proposed RESUS clinical trial of Hemopure in trauma may be contingent upon further funding.
* $5,102,306 of the $6,500,000 appropriated to the Army is from Grant DAMD17-02-1-0697. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014, is the awarding and administering acquisition office.
Contact:
Douglas Sayles
Biopure Corporation
(617) 234-6826
IR@biopure.com
----------------------------
Source: Biopure Corporation
Indeed, prof.
Thanks for the translation, prof. Excellent! I needed that...it was reassuring.
"Greco'd" IS a possibility. :(
These two quotes from the filing say it all:
"After the recission of the Agreement with Core Energy, LLC, our Company will have liabilities of approximately $1,200,000 and extremely limited assets. We will not receive meaningful additional revenues until we select an industry in which to commence business or complete an acquisition, reorganization or merger."
"The Company is currently an agent for Con Tech 21 selling long distance telecommunication services. In addition, the Company is selling a voice over the internet phone. Based on the Company's current financial structure we will not be able to continue to market these products or services."
So basically, we're at Square 1, again....and with no money to even fire up the drawing board. So, we either [1] Acquire a company (putting us in even more debt), [2] Wait for someone to buy us out (far from likely, IMO), or [3] File Bankruptcy or Dissolve or etc.
IMO, the future is bleak. If you disagree, good. Please tell me why, because I need my spirits raised.
GLTA
High volume and hitting .0001 now. More dilution? If we actually HAD news from this company, I'd be tempted to buy more at these prices.
How about some numbers regarding the sales of the CPhones? Pretty please? Oh, and the filing too?
Ah yes. My streamer does show the adjusted BPUR chart under BPURD. However, my account and my streamer show my BPUR holdings under the number 1320135, instead of BPUR (or BPURD). I assume this will change in the next day or two. Have you noticed that your holdings are listed under a number (cusip?) instead of the usual ticker?
Yes, indeed. A pretty certificate, so at least you got SOMEthing out of the company. hehe. I think they have promise, but things are taking too long to pan out. I'm not sure what's in store for this company. I certainly wish them the best!
That's quite possible. I've not heard anything about a ticker change, but I wouldn't be surprised.
I did get another PR notice in my stock streamer that said NASDAQ made an "internal administrative oversight," so the 1 for 6 split WILL take effect on Tuesday.
Yeah, they've said the split was supposed to take effect by this morning's opening, but I have yet to see any change happen. Perhaps on Tuesday?